Abstract
Meperidine is a potent narcotic related chemically and pharmacologically to morphine and atropine. To examine its gastric antisecretory activity a study designed to test the effect of meperidine on basal acid secretion was carried out: 100 mg of meperidine given intramuscularly reduced basal acid output (BAO) by 66.3% at 1 hr (P<0.001), 64.9% at 2 hr (P<0.001), and 44.9% at 3 hr (P=0.005). This degree of reduction of BAO by this dose of meperidine did not differ from that produced by 30 mg of propantheline intramuscularly. These results demonstrate that meperidine in standard classical doses is a potent inhibitor of BAO in man.
Similar content being viewed by others
References
Eisleb O, Schaumann O: Dolatin, ein neuartiges Spasmolitykum und Analgetikum (Chemisches und Pharmakologisches). Dtsch Med Wochenschr 65:967–968, 1939
Harris LS: Narcotic antagonists: Structure-activity relationships. Narcotic Antagonists. MC Braude, LS Harris, EL May, JP Smith, JE Villarreal (eds). New York, Raven Press, 1974, pp 13–20
Eddy NB, Halback H, Braendon OJ: Synthetic substances with morphine like effect. Clinical experience: Potency, side-effects, addiction, liability. Bull WHO 17:569–863, 1957
Ivey KJ: Anticholinergics: Do they work in peptic ulcers? Gastroenterology 68:154–166, 1975
Meeroff JC, Ferreira JA, Meeroff M: Medical vagotomy: New evidences of its potential usefulness as a preoperative test. Am J Dig Dis 19:617–622, 1974
Innes JR, Nickerson M: Atropine, scopolamine and related antimuscarimic drugs. The Pharmacological Basis of Therapeutics, 5th ed. LS Goodman, D Gilman (eds). New York, Macmillan, 1975, p 524
Eichhorn R, Tracktir J: The effect of hypnosis upon gastric secretion. Gastroenterology 29:417–421, 1955
Faber RG, Hobsley M: Basal gastric secretion: reproducibility and relationship with duodenal ulceration. Gut 18:57–63, 1977
Snedecor GW, Cochran WG: Statistical Methods. Ames, Iowa University Press, 1968, pp 91–119
Colquhoun D: Lectures on Biostatistics. Oxford, Clarendon Press, 1971, pp 143–148
Henn RM, Isenberg JI, Maxwell B: Inhibition of gastric acid secretion by cimetidine in patients with duodenal ulcer. N Engl J Med 293:371–375, 1975
Konturek SJ: Drug-induced inhibition of gastric secretion. Scand J Gastroenterol 11 (Suppl 42):101–111, 1976
Wang RIH, Bain JA: Analgesics and enzymes of cytochrome chain. J Pharmacol Exp Ther 108:354–361, 1953.
Lees GM, Kosterlitz HW, Waterfield AA: Characteristics of morphine-sensitive release of neurotransmitter substances. Agonist and Antagonists. Actions of Narcotic Analgesic Drugs. HW Kosterlitz, HOJ Collier, JE Villarreal (eds). Baltimore, University Park Press, 1973, pp 142–152
Eckenhoff JE, Helrich M: Study of narcotics and sedatives for use in preanesthetic medication. JAMA 167:415–422, 1958
Yonkman FF: Pharmacology of Demerol and its analogues. Ann NY Acad Sci 51:59–82, 1948
Zeppa R, Grossekreutz DC, Sugioka K: Histamine release into circulation by meperidine (Demerol). Proc Soc Exp Biol Med 106:794–796, 1961
Douglas WW: Histamine and antihistamines, 5 Hydroxytroptamine and antagonists. The Pharmacological Basis of Therapeutics, 5th ed. LS Goodman, D Gillman (eds). New York, Macmillan, 1975, p 605
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Meeroff, J.C., Fernandez, G.G. & Gaon, D. Potent reduction of basal acid output produced by meperidine. Digest Dis Sci 23, 696–698 (1978). https://doi.org/10.1007/BF01072354
Issue Date:
DOI: https://doi.org/10.1007/BF01072354